ESRP1-mediated biogenesis of circPTPN12 inhibits hepatocellular carcinoma progression by PDLIM2/ NF-κB pathway
Yang Ji(Chinese People's Liberation Army), Xuehao Wang(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 27
Related Papers
The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects
|Signal Transduction and Targeted Therapy|2020|1.1k
HIF-1α-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation
|Signal Transduction and Targeted Therapy|2021|378
PRDM1/BLIMP1 induces cancer immune evasion by modulating the USP22-SPI1-PD-L1 axis in hepatocellular carcinoma cells
|Nature Communications|2022|116
MiR-3662 suppresses hepatocellular carcinoma growth through inhibition of HIF-1α-mediated Warburg effect
|Cell Death and Disease|2018|115
GYY4137, a hydrogen sulfide (H2S) donor, shows potent anti-hepatocellular carcinoma activity through blocking the STAT3 pathway
|International Journal of Oncology|2014|111